As global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...

As the market grappled with confusion over the Strait of Hormuz, there was more trouble for the bulls. After a few days of respite, another...

The shift reflects a structural change in how multinationals use their India operations, moving beyond cost-focused support roles to centre...

Global firms are bringing more work in-house at their India centres. Artificial intelligence is boosting productivity. This reduces relianc...

Gland Pharma stock surged to a 52-week high following robust March quarter and full-year results. Its European unit, Cenexi, is improving p...

HAB Pharma and Signature Phytochemicals have merged, creating a consolidated entity with a turnover of Rs600 crore. This strategic move aim...

Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...

Social Security COLA update 2027: Gas prices in America have surged above $4.10 per gallon, up sharply from $3.17 last year, and the impact...

The Narcotics Control Bureau has arrested Thancintuang, a key Myanmar-based drug trafficker. He is a major supplier of Methamphetamine and ...

The economy of attrition is the big new reality of the battlefield. Expensive defences are badly struggling against waves of cheap drones a...

The recent decision by US President Donald Trump to impose a 100 per cent tariff on patented pharmaceutical imports to US is unlikely to ca...

Scientists are developing AI-designed molecular syringes. These syringes use modified bacterial proteins. They target specific cells for dr...

Having got a US patent in April this year, Kumar claims his precision-targeted drug delivery system is market-ready. “I think we will go in...

The MoU will advance the "Purdue Moves" drug discovery initiative to translate basic research into life-changing treatments, the release sa...

The major hurdle has been that as these local cues are not consistent between cells; one needs systems that respond to multiple such cues.

Venus Remedies is developing a new drug delivery platform that promises to reduce side effects and cost of cancer medicine by as much as on...

US-Based $23-billion diversified technology firm 3M is in talks with top domestic pharma companies to licence drug delivery technologies.